Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 234
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Usona Files Psilocybin for Depression NDA as Race With Compass Tightens
Jackie Tileston: Nondual Mysticism, 5-MeO-DMT, and the Trouble with Psychedelic Art
FDA Approves NRx’s Preservative-Free Generic Ketamine, but Its Bid to Ban Rivals’ Products Remains Pending
Weekly Psychedelic Policy Briefing: Oct. 27, 2026
PT271 – Jeremy Narby, Ph.D. – Anthropology, Ayahuasca, and Plant Teachers
Preparing for COMPASS Pathways’ Phase Data Readout: 2b, or not to...
Psychedelic Bulletin: COMPASS Targets PTSD; Detroit Decriminalizes Psychedelics; We Speak to...
PharmaDrug Advances Psychedelics Program with Analogue DMT Formulations to Treat Eye...
MindMed Appoints Dr. Maria Oquendo to its Scientific Advisory Board
PT270 – Dr. Rachel Yehuda – Research Trials and The Future...
Complete Results from Red Light Oregon Market Research in Oregon Show...
Cybin Granted DEA Schedule I Manufacturing License
MINDCURE Provides Update on Studies and Clinical Trials
The Missing Mushroom: Psychedelic Science and the Future of Psilocybin
Load more